CNVCF / BioHarvest Sciences achieves 'significant milestone' with US sales of VINIA topping US$1M in August

BioHarvest Sciences Inc said it has closed the first tranche of its previously-annouced C$13.5 million non-brokered private placement of convertible n more_horizontal

BioHarvest Sciences Inc has announced its intention to raise proceeds of up to $12 million in a non-brokered private placement of convertible notes.� more_horizontal

BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) announced it has received a Canadian product license for VINIA from Health Canada's Natural and Non-P more_horizontal

BioHarvest Sciences Inc. (OTCQB:CNVCF) Q2 Shareholder Presentation Call September 6, 2023 2:30 PM ET Company Participants Justin Meiklem - Investor Re more_horizontal

BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) has announced that monthly US sales of its flagship VINIA product surpassed $1 million in August 2023. more_horizontal

BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) chief medical officer Dr. Brian Cornblatt can speak to the effectiveness of the company's red grape-ba more_horizontal

Imagine a world where we harness the power of plants to improve human wellness without harming the environment. Israeli biotech innovator BioHarvest S more_horizontal

BioHarvest Sciences Inc. (OTCQB:CNVCF) Q2 Marketing and Performance Update Conference Call June 22, 2023 2:00 PM ET Company Participants Justin Meikle more_horizontal